Search

everythinglearnresearchcommunity

for

Search:↓

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Melatonin may reduce skin damage caused by X-rays in rats.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Premature hair graying in young men is linked to family history, obesity, and smoking.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Using psychological treatments can help manage skin conditions along with regular medical care.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Hair microRNAs could be effective biomarkers for diagnosing scleroderma.

Micropigmentation is a widely accepted tattooing technique for hiding cosmetic issues and medical uses, with permanent results and few side effects, but risks infection if not done with sterile tools.

Par3 protein is essential for skin cell balance and stability.

The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.

Bimatoprost is safe and effective for improving eyebrow hair.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Type I interferons play a key role in the development of various skin diseases.

Disruptions in epidermal polarity genes can lead to skin diseases.

Hedychium spicatum has medicinal properties but needs more research for scientific validation and use.

MALDI Imaging Mass Spectrometry is a useful method for studying skin conditions, but sample preparation is crucial for accurate results.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

SCF and ET-1 together significantly increase skin pigmentation and melanin production.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

The review found that different stem cell types in the skin are crucial for repair and could help treat skin diseases and cancer.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.